+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enzyme-linked Immunosorbent Assay (ELISA) Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report

  • 255 Pages
  • March 2023
  • Region: Global
  • Infinium Global Research
  • ID: 4848349
The report on the global enzyme-linked immunosorbent assay (ELISA) testing market provides qualitative and quantitative analysis for the period from 2021-2030. The global enzyme-linked immunosorbent assay (ELISA) testing market was valued at USD 2.47 billion in 2022 and is expected to reach USD 3.66 billion in 2030, with a CAGR of more than 5.09% during the forecast period 2023-2030. The study on enzyme-linked immunosorbent assay (ELISA) testing market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

Enzyme-linked immunosorbent assay (ELISA) testing is a laboratory technique used to detect and quantify specific proteins, such as antibodies or antigens, in a sample by using antibodies that bind to the target protein and a color-changing reaction for detection. The surge in global cancer cases has become a primary driver of the enzyme-linked immunosorbent assay (ELISA) testing market's expansion. Factors contributing to increased cancer rates include lifestyle choices like smoking and poor dietary habits, environmental influences like pollution and radiation exposure, an aging population, and genetic disorders. According to the World Health Organization, cancer was responsible for nearly 10 million deaths in 2020, highlighting its global impact. ELISA plays a crucial role in cancer diagnosis and monitoring by enabling precise detection and quantification of cancer-related biomarkers, facilitating early detection, accurate prognosis, and treatment evaluation. Consequently, ELISA tests are in high demand in healthcare and research. Additionally, the market is benefiting from the rising prevalence of infectious diseases, including HIV, dengue, hepatitis, malaria, and influenza. In 2020, approximately 37.7 million people were living with HIV worldwide, as per WHO data from July 2022. This growing disease burden underscores the demand for diagnostic tools like ELISA tests.

The "Sandwich ELISA" segment of the enzyme-linked immunosorbent assay (ELISA) testing market commands the largest market share. Sandwich ELISA is a type of enzyme-linked immunosorbent assay (ELISA) that is used to detect and quantify antigens in a sample. It is one of the most sensitive and widely used immunoassay techniques. Furthermore, A significant driving factor for ELISA testing's widespread adoption is its exceptional sensitivity, enabling the detection of minute antigen levels in samples. Its specificity allows the precise identification of target antigens, even amidst other substances, while its quantitative capabilities provide accurate antigen quantification. Additionally, the simplicity of ELISA procedures, compatible with diverse equipment and reagents, makes it an accessible and versatile choice for diagnostics and research, further fueling its popularity. Sand which ELISA testing is used to diagnose a wide range of diseases, including HIV, hepatitis, and cancer. Therefore, owing to the increasing prevalence of both communicable and non-communicable diseases the Sandwich ELISA segment is anticipated to hold largest market share in the ELISA market.

The North America region is poised to hold the largest market share in the global enzyme-linked immunosorbent assay (ELISA) testing market. The prominent position of North America in the global ELISA testing market can be ascribed to the escalating incidence of chronic illnesses, infectious diseases, and a growing elderly population. Notably, the National Center for Chronic Disease Prevention reports that 4 out of 10 American adults grapple with two or more chronic conditions, creating a sustained need for ELISA tests and driving market growth. Furthermore, substantial R&D investments from government bodies and pharmaceutical companies, particularly in the study of chronic diseases and diabetes, are pivotal factors fueling the regional market. For instance, the Pharmaceutical Research and Manufacturers of America disclosed that the biopharmaceutical industry channeled approximately USD 102.3 billion into research and development in 2021. Additionally, North America's robust healthcare infrastructure and emphasis on cutting-edge medical diagnostics significantly contribute to the demand for ELISA testing.

Report Findings

1) Drivers

  • The rising prevalence of various diseases, including infectious diseases, autoimmune disorders, and cancer, is driving the demand for ELISA testing as it offers accurate and reliable diagnostic results.
  • Growth in life sciences research, spanning drug discovery, biomarker identification, and genomics, directly fuels ELISA market expansion.

2) Restraints

  • Elisa market faces competition from faster, more sensitive alternatives like PCR, next-gen sequencing, and crispr-based assays. Its cost and complexity restrict accessibility, prompting researchers to seek cost-effective alternatives.

3) Opportunities

  • The growing trend towards personalized medicine and targeted therapies presents a significant opportunity to meet increased demand for custom ELISA tests designed to align with specific patient profiles and treatment strategies.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global enzyme-linked immunosorbent assay (ELISA) testing market is segmented on the basis of type, application, and end user.

The Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type

  • Direct ELISA
  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and Portable ELISA
  • Competitive ELISA

The Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application

  • Immunology
  • Inflammation
  • Infectious Diseases
  • Cancer, Protein Quantitation
  • Others Applications

The Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Biotechnological Companies
  • Research and Academic Institute
  • Others

Company Profiles

The companies covered in the report include
  • Agilent Technologies, Inc
  • Thermo Fisher Scientific Inc.
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • ZEUS Scientific, Inc.
  • Abcam plc.
  • bioMérieux
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the enzyme-linked immunosorbent assay (ELISA) testing market.
2. Complete coverage of all the segments in the enzyme-linked immunosorbent assay (ELISA) testing market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global enzyme-linked immunosorbent assay (ELISA) testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Enzyme-linked Immunosorbent Assay (ELISA) Testing Market Highlights
2.2. Enzyme-linked Immunosorbent Assay (ELISA) Testing Market Projection
2.3. Enzyme-linked Immunosorbent Assay (ELISA) Testing Market Regional Highlights
Chapter 3. Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Type
3.4.2. Growth Matrix Analysis by Application
3.4.3. Growth Matrix Analysis by End User
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
Chapter 4. Enzyme-linked Immunosorbent Assay (ELISA) Testing Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
5.2. Companies Profiles
5.2.1. Agilent Technologies, Inc
5.2.2. Thermo Fisher Scientific Inc.
5.2.3. Ortho Clinical Diagnostics
5.2.4. Thermo Fisher Scientific Inc.
5.2.5. ZEUS Scientific, Inc.
5.2.6. Abcam plc.
5.2.7. bioMérieux
5.2.8. Neogen Corporation
5.2.9. Bio-Rad Laboratories, Inc.
5.2.10. Bio-Techne
Chapter 6. Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
6.1. Direct ELISA
6.2. Sandwich ELISA
6.3. Indirect ELISA
6.4. Multiple and Portable ELISA
6.5. Competitive ELISA
Chapter 7. Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
7.1. Immunology
7.2. Inflammation
7.3. Infectious Diseases
7.4. Cancer, Protein Quantitation
7.5. Others Applications
Chapter 8. Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
8.1. Hospitals
8.2. Clinical Laboratories
8.3. Pharmaceutical Companies
8.4. Biotechnological Companies
8.5. Research and Academic Institute
8.6. Others
Chapter 9. Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Region 2023-2030
9.1. North America
9.1.1. North America Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.1.2. North America Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.1.3. North America Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.1.4. North America Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Country
9.1.4.1. The U.S. Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.1.4.1.1. The U.S. Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.1.4.1.2. The U.S. Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.1.4.1.3. The U.S. Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.1.4.2. Canada Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.1.4.2.1. Canada Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.1.4.2.2. Canada Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.1.4.2.3. Canada Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.1.4.3. Mexico Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.1.4.3.1. Mexico Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.1.4.3.2. Mexico Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.1.4.3.3. Mexico Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.2. Europe
9.2.1. Europe Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.2.2. Europe Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.2.3. Europe Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.2.4. Europe Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Country
9.2.4.1. Germany Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.2.4.1.1. Germany Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.2.4.1.2. Germany Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.2.4.1.3. Germany Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.2.4.2. United Kingdom Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.2.4.2.1. United Kingdom Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.2.4.2.2. United Kingdom Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.2.4.2.3. United Kingdom Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.2.4.3. France Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.2.4.3.1. France Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.2.4.3.2. France Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.2.4.3.3. France Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.2.4.4. Italy Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.2.4.4.1. Italy Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.2.4.4.2. Italy Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.2.4.4.3. Italy Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.2.4.5. Rest of Europe Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.2.4.5.1. Rest of Europe Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.2.4.5.2. Rest of Europe Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.2.4.5.3. Rest of Europe Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.3. Asia Pacific
9.3.1. Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.3.2. Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.3.3. Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.3.4. Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Country
9.3.4.1. China Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.3.4.1.1. China Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.3.4.1.2. China Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.3.4.1.3. China Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.3.4.2. Japan Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.3.4.2.1. Japan Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.3.4.2.2. Japan Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.3.4.2.3. Japan Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.3.4.3. India Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.3.4.3.1. India Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.3.4.3.2. India Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.3.4.3.3. India Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.3.4.4. South Korea Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.3.4.4.1. South Korea Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.3.4.4.2. South Korea Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.3.4.4.3. South Korea Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.3.4.5. Australia Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.3.4.5.1. Australia Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.3.4.5.2. Australia Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.3.4.5.3. Australia Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.3.4.6. Rest of Asia-Pacific Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.3.4.6.1. Rest of Asia-Pacific Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.3.4.6.2. Rest of Asia-Pacific Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.3.4.6.3. Rest of Asia-Pacific Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.4. RoW
9.4.1. RoW Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.4.2. RoW Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.4.3. RoW Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.4.4. RoW Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Sub-region
9.4.4.1. Latin America Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.4.4.1.1. Latin America Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.4.4.1.2. Latin America Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.4.4.1.3. Latin America Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.4.4.2. Middle East Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.4.4.2.1. Middle East Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.4.4.2.2. Middle East Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.4.4.2.3. Middle East Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User
9.4.4.3. Africa Enzyme-linked Immunosorbent Assay (ELISA) Testing Market
9.4.4.3.1. Africa Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Type
9.4.4.3.2. Africa Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by Application
9.4.4.3.3. Africa Enzyme-linked Immunosorbent Assay (ELISA) Testing Market by End User

Companies Mentioned

  • Agilent Technologies, Inc
  • Thermo Fisher Scientific Inc.
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • ZEUS Scientific, Inc.
  • Abcam plc.
  • bioMérieux
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne

Table Information